NCT00979316View on ClinicalTrials.gov

Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Alzheimer Disease
Interventions
DRUG

BMS-708163

Oral Solution, Oral, 800 mg, Once on Day 1, approximately 14 days

DRUG

BMS-708163

Oral Solution, Oral, 200 mg, Once on Day 1, approximately 14 days

DRUG

Placebo

Oral Solution, Oral, 0 mg, Once on Day 1, approximately 14 days

DRUG

Moxifloxacin

Tablets, Oral, 400 mg, Once on Day 1, approximately 14 days

Trial Locations (1)

85283

Mds Pharma Services (Us), Inc, Tempe

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY